Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Promising trial results for glaucoma device:

This article was originally published in Clinica

Executive Summary

Staar Surgical plans to submit its AQUA-FLOW collagen glaucoma drainage device to the US FDA a year earlier than originally intended, following promising preliminary results from a clinical study of the product. The company, which has completed the enrolment stage of the study, said early data showed that the control of intraocular pressure by the device was "excellent with minimal dependence on post-operative glaucoma drugs". Monrovia, California-based Staar plans to submit one-year data on the first 100 patients for US approval in the first quarter of 2000, rather than the two-year follow-up in the study protocol.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079467

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel